| 1 |
33836600 | Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2. | 2021 Mar 16 |
2 |
| 2 |
33993098 | OLFML2A is necessary for anti-triple negative breast cancer effect of selective activator protein-1 inhibitor T-5224. | 2021 Aug |
3 |
| 3 |
32201082 | Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines. | 2020 May 21 |
2 |
| 4 |
29476740 | A selective c-Fos/AP-1 inhibitor prevents cartilage destruction and subsequent osteophyte formation. | 2018 Mar 4 |
1 |